Regeneron Pharmaceuticals | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
AbbVie USD 3.32B 2.71B 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Astellas Pharma JPY 1.51T 19.45B 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
J&J USD 78.11B 6.62B 2025-03
Kyowa Hakko Kirin JPY 831.42B 19.39B 2025-03
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Regeneron Pharmaceuticals رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.